1
EXHIBIT 11
HEMISPHERx BIOPHARMA, INC.
STATEMENTS REGARDING COMPUTATION OF
NET LOSS PER SHARE
For the three months ended June 30, 1995 and 1996
Three Months Ended
June 30,
(unaudited)
----------------------------------------
1995 1996
---- ----
NET LOSS PER SHARE (PROFORMA)
Net Loss: $ (785,628) $ (1,074,378)
======= =========
Shares:
Weighted average number of common shares
outstanding during the period 7,253,420 15,581,729
Incremental shares representing:
Options and warrants issued within one
year period prior to an initial public offering 3,858,538 -
Conversion of Preferred Stock to Common
Stock 1,952,214 -
--------- ----------
Weighted average number of shares used in
calculating net loss per share 13,064,172 15,581,729
========== ==========
Net loss per share $ (.06) $ (.07)
========== ==========
14